NBSE - NeuBase Therapeutics stock continues slumping prices $40M public offering

NeuBase Therapeutics (NBSE) prices an underwritten public offering of 8M shares of its common stock, at a price to the public of $5.00 per share; gross proceeds $40M.Underwriters' 30-day option to purchase up to an additional 1.2M shares.Net proceeds to be used for general corporate purposes, working capital and development of its product candidates and pipeline expansion.Offering is expected to close on or about April 26, 2021.Shares slump 10% during pre-market hours.

For further details see:

NeuBase Therapeutics stock continues slumping, prices $40M public offering